The IV Equipment Market is undergoing an important transformation as healthcare delivery increasingly moves beyond hospitals into ambulatory and home-care environments. The global industry was valued at USD 24.12 billion in 2024 and is expected to reach USD 34.0 billion by 2035, registering a CAGR of 3.17% during 2025–2035.

The shift toward home healthcare is creating demand for compact, portable, and easy-to-use IV equipment. Patients who require ongoing intravenous therapies may benefit from treatment options that reduce the need for repeated hospital visits. This trend is encouraging manufacturers to develop equipment designed for safer use outside traditional clinical environments.

Portable infusion pumps are particularly relevant to this transition. Modern systems can provide controlled medication delivery while incorporating monitoring and safety features. Improvements in device design can make intravenous treatment more convenient for patients and healthcare professionals.

The home-care setting is identified as the fastest-growing end-user segment. This growth is supported by increasing patient preference for convenient treatment, healthcare cost considerations, and advances in infusion technology. Home-based infusion programs have also demonstrated high patient satisfaction in multiple clinical studies, further supporting the transition toward decentralized care.

Hospitals nevertheless remain dominant, accounting for approximately 67.2% of the market in 2024. Hospitals continue to require large volumes of IV equipment because intravenous therapies are integral to emergency treatment, surgery, oncology, intensive care, and inpatient management.

Technological innovation is helping bridge the gap between hospital and home environments. Connected infusion systems, remote monitoring, improved alarms, and portable designs can enable healthcare providers to monitor therapy more effectively.

North America remains the leading regional market, supported by advanced healthcare infrastructure and strong demand for intravenous therapies. Europe represented the second-largest regional market with a value of USD 6.0 billion in 2024, while Asia-Pacific is gaining traction as healthcare access and infrastructure improve.

As healthcare becomes increasingly patient-centric, the combination of portability, connectivity, and safety is expected to create significant opportunities across the IV Equipment Market.